Affiliation:
1. Instituto de Tecnologia em Farmacos Farmanguinhos, FIOCRUZ Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil
2. Instituto de Pesquisas Clinicas Evandro Chagas, Departament of Bacteriology, FIOCRUZ Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil
3. Instituto de Ciencias Biologicas, Universidade Federal de Juiz de Fora, Juiz de Fora-MG, Brazil
Abstract
Background:
Oximes and nitrofuranyl derivatives are particularly important compounds
in medicinal chemistry. Thus, many researchers have been reported to possess antibacterial,
antiparasitic, insecticidal and fungicidal activities.
Methods:
In this work, we report the synthesis and the biological activity against Mycobacterium
tuberculosis H37RV of a series of fifty aryl oximes, ArCH=N-OH, I, and eight nitrofuranyl compounds,
2-nitrofuranyl-X, II.
Results:
Among the oximes, I: Ar = 2-OH-4-OH, 42, and I: Ar = 5-nitrofuranyl, 46, possessed the
best activity at 3.74 and 32.0 µM, respectively. Also, 46, the nitrofuran compounds, II; X = MeO,
55, and II: X = NHCH2Ph, 58, (14.6 and 12.6 µM, respectively), exhibited excellent biological activities
and were non-cytotoxic.
Conclusion:
The compound 55 showed a selectivity index of 9.85. Further antibacterial tests were
performed with compound 55 which was inactive against Enterococcus faecalis, Klebisiella
pneumonae, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhymurium and Shigella
flexneri. This study adds important information to the rational design of new lead anti-TB drugs.
Structure-activity Relationship (SAR) is reported.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference29 articles.
1. World Health Organization. Global Report Tuberculosis 2016. ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1">http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 (Accessed August, 15, 2018)
2. Cunico W.; Gomes C.R.B.; Ferreira M.L.G.; Ferreira T.G.; Cardinot D.; de Souza M.V.N.; Lourenço M.C.S.; Synthesis and anti-mycobacterial activity of novel amino alcohol derivatives. Eur J Med Chem 2011,46(3),974-978
3. Da Costa C.F.; Pinheiro A.C.; De Almeida M.V.; Lourenço M.C.S.; De Souza M.V.N.; Synthesis and antitubercular activity of novel amino acid derivatives. Chem Biol Drug Des 2012,79(2),216-222
4. Gomes C.R.B.; Moreth M.; Facchinetti V.; De Souza M.V.N.; Júnior W.T.V.; Lourenço M.C.S.; Cunico W.; Synthesis and Antimycobacterial activity of 2-aryl-3-(arylmethyl)-1,3-thiazolidin-4-ones. Lett Drug Des Discov 2010,7,353-358
5. Ackart D.F.; Lindsey E.A.; Podell B.K.; Melander R.J.; Basaraba R.J.; Melander C.; Reversal of Mycobacterium tuberculosis phenotypic drug resistance by 2-aminoimidazole-based small molecules. Pathog Dis 2014,70(3),370-378
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献